Sulindac

舒林酸

Report date: 2026/01/22 16:41:53
NME

Base Information

Drug NameSulindac
Drug Alias Name硫茚酸Sulindacumsulindaco舒休酸苏灵大 +[12] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsTobacco Use DisorderBursitisOsteoarthritis +[15] 
Global Approved IndicationsBursitisOsteoarthritisArthritis, Gouty +[7] 
Approved Indications in ChinaOsteoarthritisArthritis, RheumatoidJoint Diseases
Original Approved Country/TerritoryUnited States
Original Approved Date1978/09/27
Country/TerritoryCanadaUnited StatesNetherlands +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesDuke UniversityMedical University Of South CarolinaNingbo Dahongying Pharmaceutical Co Ltd
Inactive CompaniesRadboud University Medical CenterNational Cancer InstituteMerck & Co Inc
Active IndicationsOsteoarthritisArthritis, RheumatoidJoint Diseases +[5] 
Inactive IndicationsTobacco Use DisorderBursitisArthritis, Gouty +[10] 

Other Information

ATC CodeM01AB02
Related LinksWikipediaDrugBankKEGG